chenodeoxycholic acid has been researched along with Alloxan Diabetes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Salami, H; Chester, J; Danic, M; Dass, C; Ionescu, CM; Johnston, E; Jones, M; Kovacevic, B; Mikov, M; Mooranian, A; Wagle, SR; Walker, D | 1 |
| Al-Salami, H; Golocorbin-Kon, S; Grujic-Letic, N; Mikov, M; Mooranian, A; Raškovic, A; Stilinovic, N; Teofilovic, B | 1 |
| Al-Salami, H; Goločorbin-Kon, S; Ionescu, CM; Kovačević, B; Luna, G; Mikov, M; Mooranian, A; Takechi, R; Zamani, N | 1 |
| Adorini, L; D'Agati, V; Dobrinskikh, E; Dvornikov, A; Field, A; Garcia, G; Gonzalez, FJ; Gratton, E; Henriksen, K; Herman-Edelstein, M; Hill, A; Jiang, T; Kopp, JB; Krausz, KW; Levi, J; Levi, M; Lucia, S; Luo, Y; Myakala, K; Orlicky, D; Peng, Y; Pruzanski, M; Qiu, L; Ranjit, S; Rosenberg, AZ; Wang, D; Wang, XX; Xie, C | 1 |
| Chen, D; Chen, W; Liu, HL; Wang, X; Wu, ZH; Zeng, TS; Zhang, HM; Zhang, ZZ | 1 |
| Al-Salami, H; Butt, G; Mikov, M; Tucker, I | 1 |
| Al-Salami, H; Butt, G; Golocorbin-Kon, S; Mikov, M; Tucker, I | 1 |
| Byun, Y; Kim, SK; Lee, DY; Lee, J; Lee, S; Lee, Y | 1 |
| Akiyoshi, T; Ishikawa, Y; Uchida, K | 1 |
| Hassan, AS; Subbiah, MT; Yunker, RL | 1 |
| Hassan, AS; Hedeen, K; Subbiah, MT | 1 |
| Kadowaki, M; Matsubara, T; Nomura, Y; Takase, H; Takeuchi, N; Uchida, K | 1 |
| Ayaki, Y; Ogura, Y | 1 |
| Akiyoshi, T; Makino, S; Uchida, K | 1 |
14 other study(ies) available for chenodeoxycholic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Chenodeoxycholic Acid Pharmacology in Biotechnology and Transplantable Pharmaceutical Applications for Tissue Delivery: An Acute Preclinical Study.
Topics: Animals; Biotechnology; Capsules; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gastrointestinal Agents; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C | 2021 |
Pharmacological effects of novel microvesicles of basil, on blood glucose and the lipid profile: a preclinical study.
Topics: Alloxan; Animals; Blood Glucose; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Lipids; Male; Microvessels; Ocimum basilicum; Plant Extracts; Rats; Rats, Wistar | 2021 |
Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation.
Topics: Acrylates; Animals; Bile Acids and Salts; Blood Glucose; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Feces; Insulin; Lithocholic Acid; Mice; Nanoconjugates; Ursodeoxycholic Acid | 2020 |
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Topics: Albuminuria; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol; Cholic Acids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Endoplasmic Reticulum Stress; Fibrosis; Glomerular Mesangium; Humans; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitochondria; Obesity; Oxidative Stress; Podocytes; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Triglycerides | 2018 |
Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Topics: Animals; Body Weight; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Gluconeogenesis; Glucose-6-Phosphatase; Liver; Male; Phosphoenolpyruvate Carboxykinase (ATP); Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors | 2016 |
Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics.
Topics: Alloxan; Animals; ATP-Binding Cassette Transporters; Bile Acids and Salts; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Gliclazide; Hypoglycemic Agents; Ileum; Male; Multidrug Resistance-Associated Proteins; Permeability; Probiotics; Rats; Rats, Wistar | 2008 |
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Chenodeoxycholic Acid; Cholic Acids; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Food-Drug Interactions; Gliclazide; Hypoglycemic Agents; Injections, Intravenous; Male; Probiotics; Random Allocation; Rats; Rats, Wistar | 2012 |
A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.
Topics: Animals; Blood Glucose; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Drug Carriers; Humans; Hypoglycemic Agents; Insulin; Intestinal Absorption; Lysine; Male; Rats; Rats, Sprague-Dawley | 2005 |
Increased biliary cholesterol secretion in alloxan diabetic mice.
Topics: Animals; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol; Cholesterol, Dietary; Cholic Acids; Diabetes Mellitus, Experimental; Lipid Metabolism; Liver; Male; Mice; Phospholipids | 1984 |
Development of bile acid biogenesis in the rat: effect of neonatal thyroidectomy, adrenalectomy, and streptozotocin-induced diabetes.
Topics: Adrenalectomy; Animals; Animals, Newborn; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol; Cholic Acids; Diabetes Mellitus, Experimental; Rats; Rats, Inbred Strains; Thyroidectomy; Weaning | 1982 |
Effect of maternal diabetes on fetal bile acid metabolism in the rat.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Diabetes Mellitus, Experimental; Female; Fetus; Lithocholic Acid; Pregnancy; Pregnancy in Diabetics; Rats | 1981 |
Altered bile acid metabolism in alloxan diabetic rats.
Topics: Alloxan; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol; Cholic Acids; Diabetes Mellitus, Experimental; Feces; In Vitro Techniques; Lipid Metabolism; Lipids; Lipoproteins; Liver; Male; Rats; Sterols | 1979 |
Effect of diabetes on the metabolism of chenodeoxycholic acid in isolated perfused rat liver.
Topics: Animals; Bile; Blood Glucose; Chenodeoxycholic Acid; Cholic Acids; Diabetes Mellitus, Experimental; In Vitro Techniques; Insulin; Liver; Male; Rats; Rats, Inbred Strains | 1987 |
Altered bile acid metabolism in nonobese, spontaneously diabetic (NOD) mice.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Diabetes Mellitus, Experimental; Feces; Female; Glycosuria; Lipids; Liver; Mice; Mice, Inbred Strains; Rats | 1985 |